Company profile
InGel Therapeutics, Inc.
Leveraging regenerative medicine & tissue engineering to bring back light to patients whose world has gone dark
- Industry
- Biotechnology Research
- Employees
- 9
- Headquarters
- Boston
- Founded
- 2022
- Office locations
- 1
InGel Therapeutics, Inc. company summary
InGel Therapeutics, Inc. is a company in the Biotechnology Research industry, headquartered in Boston, founded in 2022. On LinkedIn the company has around 9 employees.
What technology does InGel Therapeutics, Inc. use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About InGel Therapeutics, Inc.
InGel Therapeutics is Harvard-spinoff, regenerative medicine biotech leveraging novel neuroprotective mechanisms to stop retinal degeneration. Our beachhead indication is Retinitis Pigmentosa, with future expansion opportunities which include Dry-AMD and Glaucoma.
Where is InGel Therapeutics, Inc. located?
InGel Therapeutics, Inc. lists 1 location.
Compare companies similar to InGel Therapeutics, Inc.
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
InGel Therapeutics, Inc. ingeltx.com | Biotechnology Research | 9 | 2022 | Boston |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about InGel Therapeutics, Inc.
What does InGel Therapeutics, Inc. do?
InGel Therapeutics is Harvard-spinoff, regenerative medicine biotech leveraging novel neuroprotective mechanisms to stop retinal degeneration. Our beachhead indication is Retinitis Pigmentosa, with future expansion opportunities which include Dry-AMD and Glaucoma.
How many employees does InGel Therapeutics, Inc. have?
InGel Therapeutics, Inc. has around 9 employees on LinkedIn.
Where is InGel Therapeutics, Inc. headquartered?
InGel Therapeutics, Inc. is headquartered in Boston.
When was InGel Therapeutics, Inc. founded?
InGel Therapeutics, Inc. was founded in 2022.
Build a lead list from companies like InGel Therapeutics, Inc.
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.